Click here to view the September edition of Dates for Your Diary

Click here to read the full edition of the September 2021 People Pathways newsletter.

A Newcastle biotech, specialising in nanorobotic technology to improve the diagnosis of some of the world’s most serious diseases, has joined Newcastle Helix. Nanovery, a biotechnology company formed in 2018, are developing nanorobots for a quick and easy test to help in the diagnosis of cancer and other diseases. The test is based on DNA nanotechnology and costs less than tissue biopsy, whilst reducing risk to patients. The company, formed in London, moved to Newcastle in 2020, to collaborate and access some of the city’s most renowned academics and partners in the field of research and…

CAMBRIDGE, UK and NEW YORK, USA, 28 September 2021: Artios Pharma Limited (Artios), a leading biotech company pioneering the development of novel small molecule therapeutics that target the DNA Damage Response process in order to treat patients suffering from a broad range of cancers, announces it has dosed the first patient in its Phase 1/2a study with its polymerase theta (Polθ) inhibitor, ART4215. The Polθ project was originally in-licensed from Cancer Research UK in 2016 as part of the initial formation of Artios. The open label, multi-center study will assess the safety, tolerability,…

Babraham, 27 September 2021: Five promising early-stage life science ventures are beginning the next steps of their entrepreneurial adventure at one of the most successful locations for life science start-ups in Europe, the Babraham Research Campus, CambridgeNow in its fourth year, Accelerate@Babraham, the bio-entrepreneurial incubator initiative established and developed by the Babraham Research Campus, has announced its 2021/22 winning cohort who begin their five-month journey today with a week-long life sciences bootcamp.The winning ventures will be able to…

We have advised Shore Capital (Nominated Adviser, Joint Broker and Joint Bookrunner) and Stifel (Joint Broker & Joint Bookrunner) on a $354 million (£265.5 million) placing and retail offer for Kape Technologies plc, a leading B2C privacy-first digital security software provider. The capital raise was structured as an accelerated bookbuild placing, and was supported by new and existing institutional shareholders, including a number of blue-chip institutional investors from the UK, USA, Israel and Asia. The proceeds of the raise will be used to fund the upfront consideration for the…

We have advised leading data-driven underwriting and risk analytics business Envelop Risk on its Series B financing of $130 million led by SoftBank Vision Fund 2. The investment is intended to support the business in expanding its proprietary machine-learning and data-driven underwriting activity in London and Bermuda, with hopes to accelerate growth into new markets globally and beyond cyber (re)insurance. Founded in 2016 with a vision of transforming how the insurance industry quantifies and manages risk, Envelop Risk underwrites bespoke reinsurance for global insurance firms,…

Israel has long been one of the world's leading exporters of online gambling and casino companies, a sector that has boomed during the pandemic. The convergence of multiple trends in the online gaming industry (the acceleration of games as social networks and content platforms, and a push toward cross-media integration, cloud gaming and subscription services) is underpinning buoyant times for investment and M&A activity in the sector. Indeed, the last few years have seen a huge acceleration of growth and increased deal activity, both from existing video games industry players and new…

Cambridge, UK, 23 Sept 2021: o2h co-work labs, a business unit of o2h Group, are absolutely delighted to launch the first ever influencer biotech bootcamp covering representatives from the quintet influencer community that are the creative forces driving biotech. The event is going to be held at the newly renovated the old Mill house at the Mill SciTech Park, where o2h co-work labs is building a community of creators covering life-science, technology and green innovation. Looking far beyond the ‘start-up’ skills the bootcamp endeavours to bring together a dozen influencers covering the…

Cambridge, UK, 27 September 2021: Chesterford Research Park is delighted to announce the expansion of an existing occupier, SuperDielectrics, into new laboratory and write up space within the Emmanuel Building. Superdielectrics first moved to Chesterford Research Park in February this year, taking a suite in the multi-occupancy Science Village building. Due to the accelerated development of its proprietary technology, the organisation required the ability to scale-up swiftly and the newly completed Emmanuel Building at the Park provided the ideal opportunity at the right time.The…